메뉴 건너뛰기




Volumn 12, Issue 1, 2015, Pages

Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid

Author keywords

Cerebrospinal fluid; Glycosylation; Immunoglobulin G; Multiple sclerosis

Indexed keywords

GLYCOPEPTIDE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1; METHOTREXATE; N ACETYLGLUCOSAMINE; PEPTIDE DERIVATIVE; AUTACOID; BIOLOGICAL MARKER; IMMUNOGLOBULIN G;

EID: 84949955706     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-015-0450-1     Document Type: Article
Times cited : (85)

References (55)
  • 1
    • 84877582501 scopus 로고    scopus 로고
    • The utility of cerebrospinal fluid analysis in patients with multiple sclerosis
    • Stangel M, Fredrikson S, Meinl E, Petzold A, Stuve O, Tumani H. The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. Nat Rev Neurol. 2013;9(5):267-76. doi: 10.1038/nrneurol.2013.41.
    • (2013) Nat Rev Neurol , vol.9 , Issue.5 , pp. 267-276
    • Stangel, M.1    Fredrikson, S.2    Meinl, E.3    Petzold, A.4    Stuve, O.5    Tumani, H.6
  • 2
    • 82955203797 scopus 로고    scopus 로고
    • B cells in multiple sclerosis: connecting the dots
    • von Büdingen HC, Bar-Or A, Zamvil SS. B cells in multiple sclerosis: connecting the dots. Curr Opin Immunol. 2011;23(6):713-20. http://dx.doi.org/10.1016/j.coi.2011.09.003.
    • (2011) Curr Opin Immunol , vol.23 , Issue.6 , pp. 713-720
    • Büdingen, H.C.1    Bar-Or, A.2    Zamvil, S.S.3
  • 3
    • 33750627447 scopus 로고    scopus 로고
    • Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment
    • Antel J, Bar-Or A. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J Neuroimmunol. 2006;180(1-2):3-8.
    • (2006) J Neuroimmunol , vol.180 , Issue.1-2 , pp. 3-8
    • Antel, J.1    Bar-Or, A.2
  • 4
    • 84861556651 scopus 로고    scopus 로고
    • Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
    • Elliott C, Lindner M, Arthur A, Brennan K, Jarius S, Hussey J, et al. Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain. 2012;135(Pt 6):1819-33. doi: 10.1093/brain/aws105.
    • (2012) Brain , vol.135 , pp. 1819-1833
    • Elliott, C.1    Lindner, M.2    Arthur, A.3    Brennan, K.4    Jarius, S.5    Hussey, J.6
  • 5
    • 0031748566 scopus 로고    scopus 로고
    • Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination
    • Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann Neurol. 1998;43(4):465-71.
    • (1998) Ann Neurol , vol.43 , Issue.4 , pp. 465-471
    • Storch, M.K.1    Piddlesden, S.2    Haltia, M.3    Iivanainen, M.4    Morgan, P.5    Lassmann, H.6
  • 6
    • 0342906187 scopus 로고    scopus 로고
    • Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination
    • Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47(6):707-17.
    • (2000) Ann Neurol , vol.47 , Issue.6 , pp. 707-717
    • Lucchinetti, C.1    Bruck, W.2    Parisi, J.3    Scheithauer, B.4    Rodriguez, M.5    Lassmann, H.6
  • 7
    • 84868525833 scopus 로고    scopus 로고
    • B cells and antibodies in multiple sclerosis pathogenesis and therapy
    • Krumbholz M, Derfuss T, Hohlfeld R, Meinl E. B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol. 2012;8(11):613-23.
    • (2012) Nat Rev Neurol , vol.8 , Issue.11 , pp. 613-623
    • Krumbholz, M.1    Derfuss, T.2    Hohlfeld, R.3    Meinl, E.4
  • 8
    • 80053578013 scopus 로고    scopus 로고
    • Impact of differential glycosylation on IgG activity crossroads between innate and adaptive immunity III
    • In: Pulendran B, Katsikis PD, Schoenberger SP, editors. New York: Springer;
    • Lux A, Nimmerjahn F. Impact of differential glycosylation on IgG activity crossroads between innate and adaptive immunity III. In: Pulendran B, Katsikis PD, Schoenberger SP, editors. Advances in Experimental Medicine and Biology. New York: Springer; 2012. p. 113-24.
    • (2012) Advances in Experimental Medicine and Biology. , pp. 113-124
    • Lux, A.1    Nimmerjahn, F.2
  • 10
    • 0028244694 scopus 로고
    • Agalactosyl glycoforms of IgG autoantibodies are pathogenic
    • Rademacher TW, Williams P, Dwek RA. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Natl Acad Sci. 1994;91(13):6123-7.
    • (1994) Proc Natl Acad Sci , vol.91 , Issue.13 , pp. 6123-6127
    • Rademacher, T.W.1    Williams, P.2    Dwek, R.A.3
  • 11
    • 84868642198 scopus 로고    scopus 로고
    • Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1
    • Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, et al. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat Med. 2012;18(9):1401-6. doi: 10.1038/nm.2862.
    • (2012) Nat Med , vol.18 , Issue.9 , pp. 1401-1406
    • Karsten, C.M.1    Pandey, M.K.2    Figge, J.3    Kilchenstein, R.4    Taylor, P.R.5    Rosas, M.6
  • 12
    • 84875410765 scopus 로고    scopus 로고
    • Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
    • Schwab I, Nimmerjahn F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol. 2013;13(3):176-89.
    • (2013) Nat Rev Immunol , vol.13 , Issue.3 , pp. 176-189
    • Schwab, I.1    Nimmerjahn, F.2
  • 13
    • 35348875440 scopus 로고    scopus 로고
    • Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis
    • Nandakumar KS, Collin M, Olsen A, Nimmerjahn F, Blom AM, Ravetch JV, et al. Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis. Eur J Immunol. 2007;37(10):2973-82.
    • (2007) Eur J Immunol , vol.37 , Issue.10 , pp. 2973-2982
    • Nandakumar, K.S.1    Collin, M.2    Olsen, A.3    Nimmerjahn, F.4    Blom, A.M.5    Ravetch, J.V.6
  • 14
    • 54449089342 scopus 로고    scopus 로고
    • In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner
    • Albert H, Collin M, Dudziak D, Ravetch JV, Nimmerjahn F. In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc Natl Acad Sci. 2008;105(39):15005-9.
    • (2008) Proc Natl Acad Sci , vol.105 , Issue.39 , pp. 15005-15019
    • Albert, H.1    Collin, M.2    Dudziak, D.3    Ravetch, J.V.4    Nimmerjahn, F.5
  • 15
    • 33746888249 scopus 로고    scopus 로고
    • Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
    • Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006;313(5787):670-3.
    • (2006) Science , vol.313 , Issue.5787 , pp. 670-673
    • Kaneko, Y.1    Nimmerjahn, F.2    Ravetch, J.V.3
  • 17
    • 84899549447 scopus 로고    scopus 로고
    • IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist
    • von Gunten S, Shoenfeld Y, Blank M, Branch DR, Vassilev T, Kasermann F, et al. IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist. Nat Rev Immunol. 2014;14(5):349. doi: 10.1038/nri3401-c1.
    • (2014) Nat Rev Immunol , vol.14 , Issue.5 , pp. 349
    • Gunten, S.1    Shoenfeld, Y.2    Blank, M.3    Branch, D.R.4    Vassilev, T.5    Kasermann, F.6
  • 18
    • 84899549447 scopus 로고    scopus 로고
    • Reply to [mdash] IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist
    • Schwab I, Lux A, Nimmerjahn F. Reply to [mdash] IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist. Nat Rev Immunol. 2014;14(5):349. doi: 10.1038/nri3401-c2.
    • (2014) Nat Rev Immunol , vol.14 , Issue.5 , pp. 349
    • Schwab, I.1    Lux, A.2    Nimmerjahn, F.3
  • 19
    • 84892696203 scopus 로고    scopus 로고
    • Lack of galactosylation enhances the pathogenic activity of IgG1 but not IgG2a anti-erythrocyte autoantibodies
    • Ito K, Furukawa J-i, Yamada K, Tran NL, Shinohara Y, Izui S. Lack of galactosylation enhances the pathogenic activity of IgG1 but not IgG2a anti-erythrocyte autoantibodies. J Immunol. 2014;192(2):581-8. doi: 10.4049/jimmunol.1302488.
    • (2014) J Immunol , vol.192 , Issue.2 , pp. 581-588
    • Ito, K.1    Furukawa, J.-I.2    Yamada, K.3    Tran, N.L.4    Shinohara, Y.5    Izui, S.6
  • 20
    • 0029563888 scopus 로고
    • Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions
    • Lifely MR, Hale C, Boyce S, Keen MJ, Phillips J. Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. Glycobiology. 1995;5(8):813-22.
    • (1995) Glycobiology , vol.5 , Issue.8 , pp. 813-822
    • Lifely, M.R.1    Hale, C.2    Boyce, S.3    Keen, M.J.4    Phillips, J.5
  • 21
    • 0033044588 scopus 로고    scopus 로고
    • Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity
    • Umana P, Jean-Mairet J, Moudry R, Amstutz H, Bailey JE. Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotech. 1999;17(2):176-80.
    • (1999) Nat Biotech , vol.17 , Issue.2 , pp. 176-180
    • Umana, P.1    Jean-Mairet, J.2    Moudry, R.3    Amstutz, H.4    Bailey, J.E.5
  • 22
    • 84857355968 scopus 로고    scopus 로고
    • An afucosylated anti-CD20 monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximab
    • Gasdaska JR, Sherwood S, Regan JT, Dickey LF. An afucosylated anti-CD20 monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximab. Mol Immunol. 2012;50(3):134-41.
    • (2012) Mol Immunol , vol.50 , Issue.3 , pp. 134-141
    • Gasdaska, J.R.1    Sherwood, S.2    Regan, J.T.3    Dickey, L.F.4
  • 23
    • 0022414766 scopus 로고
    • Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG
    • Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985;316(6027):452-7.
    • (1985) Nature , vol.316 , Issue.6027 , pp. 452-457
    • Parekh, R.B.1    Dwek, R.A.2    Sutton, B.J.3    Fernandes, D.L.4    Leung, A.5    Stanworth, D.6
  • 24
    • 79953877355 scopus 로고    scopus 로고
    • IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis
    • Selman MH, Niks EH, Titulaer MJ, Verschuuren JJ, Wuhrer M, Deelder AM. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis. J Proteome Res. 2011;10(1):143-52. doi: 10.1021/pr1004373.
    • (2011) J Proteome Res , vol.10 , Issue.1 , pp. 143-152
    • Selman, M.H.1    Niks, E.H.2    Titulaer, M.J.3    Verschuuren, J.J.4    Wuhrer, M.5    Deelder, A.M.6
  • 26
    • 84901855345 scopus 로고    scopus 로고
    • Glycosylation as a marker for inflammatory arthritis
    • Albrecht S, Unwin L, Muniyappa M, Rudd PM. Glycosylation as a marker for inflammatory arthritis. Cancer Biomark. 2014;14(1):17-28. doi: 10.3233/cbm-130373.
    • (2014) Cancer Biomark , vol.14 , Issue.1 , pp. 17-28
    • Albrecht, S.1    Unwin, L.2    Muniyappa, M.3    Rudd, P.M.4
  • 27
    • 84865637801 scopus 로고    scopus 로고
    • Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation
    • Ercan A, Barnes MG, Hazen M, Tory H, Henderson L, Dedeoglu F, et al. Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation. Arthritis Rheum. 2012;64(9):3025-33. doi: 10.1002/art.34507.
    • (2012) Arthritis Rheum , vol.64 , Issue.9 , pp. 3025-3033
    • Ercan, A.1    Barnes, M.G.2    Hazen, M.3    Tory, H.4    Henderson, L.5    Dedeoglu, F.6
  • 28
    • 84918590946 scopus 로고    scopus 로고
    • Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis
    • Rombouts Y, Ewing E, van de Stadt LA, Selman MHJ, Trouw LA, Deelder AM, et al. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis. 2013. doi: 10.1136/annrheumdis-2013-203565.
    • (2013) Ann Rheum Dis
    • Rombouts, Y.1    Ewing, E.2    Stadt, L.A.3    Selman, M.H.J.4    Trouw, L.A.5    Deelder, A.M.6
  • 29
    • 72949114659 scopus 로고    scopus 로고
    • Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo
    • Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol. 2009;66(5):630-43.
    • (2009) Ann Neurol , vol.66 , Issue.5 , pp. 630-643
    • Bradl, M.1    Misu, T.2    Takahashi, T.3    Watanabe, M.4    Mader, S.5    Reindl, M.6
  • 30
    • 72949093353 scopus 로고    scopus 로고
    • Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica
    • Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol. 2009;66(5):617-29.
    • (2009) Ann Neurol , vol.66 , Issue.5 , pp. 617-629
    • Bennett, J.L.1    Lam, C.2    Kalluri, S.R.3    Saikali, P.4    Bautista, K.5    Dupree, C.6
  • 31
    • 84873406959 scopus 로고    scopus 로고
    • Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody
    • Tradtrantip L, Ratelade J, Zhang H, Verkman AS. Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody. Ann Neurol. 2013;73(1):77-85. doi: 10.1002/ana.23741.
    • (2013) Ann Neurol , vol.73 , Issue.1 , pp. 77-85
    • Tradtrantip, L.1    Ratelade, J.2    Zhang, H.3    Verkman, A.S.4
  • 32
    • 0034773523 scopus 로고    scopus 로고
    • Effect of SpeB and EndoS from streptococcus pyogenes on human immunoglobulins
    • Collin M, Olsen A. Effect of SpeB and EndoS from streptococcus pyogenes on human immunoglobulins. Infect Immun. 2001;69(11):7187-9.
    • (2001) Infect Immun , vol.69 , Issue.11 , pp. 7187-7189
    • Collin, M.1    Olsen, A.2
  • 35
    • 77954788863 scopus 로고    scopus 로고
    • Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes
    • Yang R, Otten MA, Hellmark T, Collin M, Björck L, Zhao MH, et al. Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes. Nephrol Dial Transplant. 2010;25(8):2479-86.
    • (2010) Nephrol Dial Transplant , vol.25 , Issue.8 , pp. 2479-2486
    • Yang, R.1    Otten, M.A.2    Hellmark, T.3    Collin, M.4    Björck, L.5    Zhao, M.H.6
  • 36
    • 84902838015 scopus 로고    scopus 로고
    • In-depth method for the characterization of glycosylation in manufactured recombinant monoclonal antibody drugs
    • Song T, Ozcan S, Becker A, Lebrilla CB. In-depth method for the characterization of glycosylation in manufactured recombinant monoclonal antibody drugs. Anal Chem. 2014;86(12):5661-6. doi: 10.1021/ac501102t.
    • (2014) Anal Chem , vol.86 , Issue.12 , pp. 5661-5666
    • Song, T.1    Ozcan, S.2    Becker, A.3    Lebrilla, C.B.4
  • 37
    • 61649087668 scopus 로고    scopus 로고
    • Glycosylation as a strategy to improve antibody-based therapeutics
    • Jefferis R. Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov. 2009;8(3):226-34.
    • (2009) Nat Rev Drug Discov , vol.8 , Issue.3 , pp. 226-234
    • Jefferis, R.1
  • 38
    • 0035282811 scopus 로고    scopus 로고
    • Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs
    • Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001;184(2):101-22.
    • (2001) J Neurol Sci , vol.184 , Issue.2 , pp. 101-122
    • Reiber, H.1    Peter, J.B.2
  • 40
    • 80054016444 scopus 로고    scopus 로고
    • High throughput isolation and glycosylation analysis of IgG - variability and heritability of the IgG glycome in three isolated human populations
    • M111.010090
    • Pucic M, Knezevic A, Vidic J, Adamczyk B, Novokmet M, Polasek O, et al. High throughput isolation and glycosylation analysis of IgG - variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics. 2011;10(10):M111.010090.
    • (2011) Mol Cell Proteomics , vol.10 , Issue.10
    • Pucic, M.1    Knezevic, A.2    Vidic, J.3    Adamczyk, B.4    Novokmet, M.5    Polasek, O.6
  • 41
    • 76149085857 scopus 로고    scopus 로고
    • Immunoglobulin G glycopeptide profiling by matrix-assisted laser desorption ionization fourier transform ion cyclotron resonance mass spectrometry
    • Selman MHJ, McDonnell LA, Palmblad M, Ruhaak LR, Deelder AM, Wuhrer M. Immunoglobulin G glycopeptide profiling by matrix-assisted laser desorption ionization fourier transform ion cyclotron resonance mass spectrometry. Anal Chem. 2010;82(3):1073-81. doi: 10.1021/ac9024413.
    • (2010) Anal Chem , vol.82 , Issue.3 , pp. 1073-1081
    • Selman, M.H.J.1    McDonnell, L.A.2    Palmblad, M.3    Ruhaak, L.R.4    Deelder, A.M.5    Wuhrer, M.6
  • 42
    • 84863304598 scopus 로고    scopus 로고
    • R: A language and environment for statistical computing
    • 301st ed. Vienna, Austria: R Foundation for Statistical Computing;
    • R Core Team. R: A language and environment for statistical computing. 301st ed. Vienna, Austria: R Foundation for Statistical Computing; 2013.
    • (2013)
  • 43
    • 0001677717 scopus 로고
    • Controlling the false discovery rate-a practical and powerful approach to multiple testing
    • Benjamini Y, Hochberg Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57(1):289-300.
    • (1995) J R Stat Soc Ser B Methodol , vol.57 , Issue.1 , pp. 289-300
    • Benjamini, Y.1    Hochberg, Y.2
  • 44
    • 84936916896 scopus 로고
    • Robust locally weighted regression and smoothing scatterplots
    • Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979;74(368):829-36.
    • (1979) J Am Stat Assoc , vol.74 , Issue.368 , pp. 829-836
    • Cleveland, W.S.1
  • 45
    • 84875998684 scopus 로고    scopus 로고
    • Impact of immune complex size and glycosylation on IgG binding to human FcγRs
    • Lux A, Yu X, Scanlan CN, Nimmerjahn F. Impact of immune complex size and glycosylation on IgG binding to human FcγRs. J Immunol. 2013;190(8):4315-23. doi: 10.4049/jimmunol.1200501.
    • (2013) J Immunol , vol.190 , Issue.8 , pp. 4315-4323
    • Lux, A.1    Yu, X.2    Scanlan, C.N.3    Nimmerjahn, F.4
  • 46
    • 77952911607 scopus 로고    scopus 로고
    • Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid
    • Scherer HU, van der Woude D, Ioan-Facsinay A, el Bannoudi H, Trouw LA, Wang J, et al. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum. 2010;62(6):1620-9.
    • (2010) Arthritis Rheum , vol.62 , Issue.6 , pp. 1620-1629
    • Scherer, H.U.1    Woude, D.2    Ioan-Facsinay, A.3    Bannoudi, H.4    Trouw, L.A.5    Wang, J.6
  • 47
    • 84880708189 scopus 로고    scopus 로고
    • The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies
    • Collin M, Ehlers M. The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies. Exp Dermatol. 2013;22(8):511-4. doi: 10.1111/exd.12171.
    • (2013) Exp Dermatol , vol.22 , Issue.8 , pp. 511-514
    • Collin, M.1    Ehlers, M.2
  • 48
    • 33845478916 scopus 로고    scopus 로고
    • Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors
    • Urich E, Gutcher I, Prinz M, Becher B. Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors. Proc Natl Acad Sci. 2006;103(49):18697-702. doi: 10.1073/pnas.0607283103.
    • (2006) Proc Natl Acad Sci , vol.103 , Issue.49 , pp. 18697-18702
    • Urich, E.1    Gutcher, I.2    Prinz, M.3    Becher, B.4
  • 50
    • 0018583074 scopus 로고
    • Determination of IgG subgroups in cerebrospinal fluid of multiple sclerosis patients and others
    • Eickhoff K, Kaschka W, Skvaril F, Theilkaes L, Heipertz R. Determination of IgG subgroups in cerebrospinal fluid of multiple sclerosis patients and others. Acta Neurol Scand. 1979;60(5):277-82.
    • (1979) Acta Neurol Scand , vol.60 , Issue.5 , pp. 277-282
    • Eickhoff, K.1    Kaschka, W.2    Skvaril, F.3    Theilkaes, L.4    Heipertz, R.5
  • 51
    • 0026864887 scopus 로고
    • IgG1-IgG4 subclasses in the cerebrospinal fluid and blood serum and their synthesis in the central nervous system in multiple sclerosis
    • Losy J, Michalowska-Wender G, Wender M. IgG1-IgG4 subclasses in the cerebrospinal fluid and blood serum and their synthesis in the central nervous system in multiple sclerosis. Neurol Neurochir Pol. 1992;26(3):297-303.
    • (1992) Neurol Neurochir Pol , vol.26 , Issue.3 , pp. 297-303
    • Losy, J.1    Michalowska-Wender, G.2    Wender, M.3
  • 53
    • 17944387597 scopus 로고    scopus 로고
    • Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24
    • Müthing J, Kemminer SE, Conradt HS, Sagi D, Nimtz M, Kärst U, et al. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24. Biotechnol Bioeng. 2003;83(3):321-34.
    • (2003) Biotechnol Bioeng , vol.83 , Issue.3 , pp. 321-334
    • Müthing, J.1    Kemminer, S.E.2    Conradt, H.S.3    Sagi, D.4    Nimtz, M.5    Kärst, U.6
  • 54
    • 84903777311 scopus 로고    scopus 로고
    • CNS myelin induces regulatory functions of DC-SIGN-expressing, antigen-presenting cells via cognate interaction with MOG
    • García-Vallejo JJ, Ilarregui JM, Kalay H, Chamorro S, Koning N, Unger WW, et al. CNS myelin induces regulatory functions of DC-SIGN-expressing, antigen-presenting cells via cognate interaction with MOG. J Exp Med. 2014;211(7):1465-83. doi: 10.1084/jem.20122192.
    • (2014) J Exp Med , vol.211 , Issue.7 , pp. 1465-1483
    • García-Vallejo, J.J.1    Ilarregui, J.M.2    Kalay, H.3    Chamorro, S.4    Koning, N.5    Unger, W.W.6
  • 55
    • 84949965096 scopus 로고    scopus 로고
    • Symbol and text nomenclature for representation of glycan structure
    • Accessed 05/28/2014.
    • Functional glycomics gateway. Symbol and text nomenclature for representation of glycan structure. http://www.functionalglycomics.org/static/consortium/Nomenclature.shtml. Accessed 05/28/2014.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.